Shares of Elevance Health Inc. ELV slipped 1.42% to $405.40 Tuesday, on what proved to be an all-around great trading session ...

StockNews.com cut shares of Elevance Health (NYSE:ELV – Free Report) from a buy rating to a hold rating in a research note ...

In a report released today, Stephen Baxter from Wells Fargo maintained a Buy rating on Elevance Health (ELV – Research Report), with a price ...

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $492.5, with a ...

In a memo dated January 27 from Matthew Vaeth, Acting Director, Office of Management and Budget, sent to the heads of the federal government’s ...

Wall Street Breakfast, Seeking Alpha's flagship daily business news summary, is a one-page summary that gives you a rapid overview of the day's key financial news. It is designed for easy ...

Highlights:,Elevance Health's stock has experienced a dip in value.,The company maintains a moderate debt-to-equity ratio and ...

The companies raised prices a median 4%, though some drugs will cost thousands of dollars more.

Jan. 27, 2025 — Researchers have uncovered a significant connection between elevated uric acid levels and life-threatening outcomes in children with severe ...